Cardinal Health Downgraded to “Sell” at Jefferson Research (CAH)
Cardinal Health (NYSE:CAH) was downgraded by equities research analysts at Jefferson Research from a “hold” rating to a “sell” rating in a research note issued to investors on Friday, StockRatingsNetwork.com reports.
Cardinal Health (NYSE:CAH) traded up 0.19% on Friday, hitting $70.051. 368,970 shares of the company’s stock traded hands. Cardinal Health has a 52-week low of $41.42 and a 52-week high of $70.96. The stock’s 50-day moving average is $67.36 and its 200-day moving average is $59.37. The company has a market cap of $23.957 billion and a P/E ratio of 64.21.
Cardinal Health (NYSE:CAH) last released its earnings data on Friday, January 31st. The company reported $0.79 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.84 by $0.05. The company had revenue of $22.20 billion for the quarter, compared to the consensus estimate of $20.74 billion. Analysts expect that Cardinal Health will post $3.83 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.3025 per share. This represents a $1.21 dividend on an annualized basis and a yield of 1.73%. The ex-dividend date of this dividend is Friday, March 28th.
In other Cardinal Health news, EVP Mark Blake sold 2,330 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $68.53, for a total value of $159,674.90. Following the sale, the executive vice president now directly owns 31,941 shares in the company, valued at approximately $2,188,917. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
A number of other analysts have also recently weighed in on CAH. Analysts at Zacks reiterated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, February 4th. They now have a $83.00 price target on the stock. Separately, analysts at Sterne Agee raised their price target on shares of Cardinal Health from $73.00 to $83.00 in a research note on Friday, January 31st. Finally, analysts at Raymond James raised their price target on shares of Cardinal Health from $75.00 to $77.00 in a research note on Friday, January 31st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $67.36.
Cardinal Health, Inc is a healthcare services company providing products and services that help pharmacies, hospitals, surgery centers, physician offices and other healthcare providers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.